Laura Lehtinen
lauleh@utu.fi +358 29 450 4614 +358 50 476 5793 Kiinamyllynkatu 10 Turku ORCID identifier: https://orcid.org/0000-0001-7383-0353 |
Publications
- Prognostic and diagnostic value of REG4 serum and tissue expression in pancreatic ductal adenocarcinoma (2018)
- Tumor Biology
(A1 Refereed original research article in a scientific journal) - PLA2G7 associates with hormone receptor negativity in clinical breast cancer samples and regulates epithelial-mesenchymal transition in cultured breast cancer cells (2017)
- Journal of Pathology: Clinical Research
(A1 Refereed original research article in a scientific journal) - Characterization of ascites and tumor-derived ovarian cancer stem-like cells (2016)
- Clinical Cancer Research
(Other publication) - REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker (2016)
- PLoS ONE
(A1 Refereed original research article in a scientific journal) - FHOD1, a Formin Upregulated in Epithelial-Mesenchymal Transition, Participates in Cancer Cell Migration and Invasion (2013)
- PLoS ONE
(A1 Refereed original research article in a scientific journal) - High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion (2013)
- Oncotarget
(A1 Refereed original research article in a scientific journal) - 15-Hydroxyprostaglandin dehydrogenase associates with poor prognosis in breast cancer, induces epithelial-mesenchymal transition, and promotes cell migration in cultured breast cancer cells. (2012)
- Journal of Pathology
(A1 Refereed original research article in a scientific journal) - Identification of novel regulatory genes controlling epithelial to mesenchymal transition in cultured breast cancer cells (2012)
- Cancer Research
(Other publication) - Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression (2011)
- Cancer Research
(A1 Refereed original research article in a scientific journal) - Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins (2011)
- Oncotarget
(A1 Refereed original research article in a scientific journal)



